BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 21 filers reported holding BIOLINERX LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,334 | +13.8% | 16,667 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $26,667 | +79.8% | 16,667 | 0.0% | 0.01% | +60.0% |
| Q1 2023 | $14,834 | +50.8% | 16,667 | 0.0% | 0.01% | +66.7% |
| Q4 2022 | $9,834 | -42.2% | 16,667 | -10.7% | 0.00% | -50.0% |
| Q3 2022 | $17,000 | -29.2% | 18,667 | 0.0% | 0.01% | -25.0% |
| Q2 2022 | $24,000 | -25.0% | 18,667 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $32,000 | -15.8% | 18,667 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $38,000 | -25.5% | 18,667 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $51,000 | -1.9% | 18,667 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $52,000 | -35.0% | 18,667 | -34.9% | 0.01% | -40.0% |
| Q1 2021 | $80,000 | +11.1% | 28,667 | 0.0% | 0.02% | +5.3% |
| Q4 2020 | $72,000 | +50.0% | 28,667 | -1.1% | 0.02% | +35.7% |
| Q3 2020 | $48,000 | +60.0% | 29,000 | +62.9% | 0.01% | +40.0% |
| Q2 2020 | $30,000 | +66.7% | 17,799 | +29.0% | 0.01% | +42.9% |
| Q1 2020 | $18,000 | -33.3% | 13,799 | +17.0% | 0.01% | -22.2% |
| Q4 2019 | $27,000 | – | 11,799 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,686,375 | $2,884,000 | 0.18% |
| Senvest Management, LLC | 451,205 | $772,000 | 0.05% |
| Cutter & CO Brokerage, Inc. | 17,799 | $30,000 | 0.01% |
| Opaleye Management Inc. | 16,667 | $29,000 | 0.01% |
| Psagot Value Holdings Ltd. | 117,000 | $200,000 | 0.01% |
| Orbimed Advisors | 69,240 | $118,000 | 0.00% |
| MORGAN STANLEY | 565,114 | $966,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 18,973 | $32,000 | 0.00% |
| LPL Financial LLC | 19,876 | $34,000 | 0.00% |
| Asset Dedication, LLC | 366 | $1,000 | 0.00% |